The MDS genomics-prognosis symbiosis

Nazha, A

Nazha, A (reprint author), Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Desk CA6,9500 Euclid Ave, Cleveland, OH 44195 USA.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018; (): 270

Abstract

Myelodysplastic syndromes (MDS) are clonal disorders characterized by the accumulation of complex genomic abnormalities that define disease phenotype,......

Full Text Link